Another testing post – jetpack functionalities disabled
this is an excerpt
Adding a new post to test the excerpt process
this is an excerpt
BioLabs Pegasus Park Cultivates Life Science Ecosystem
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Testing the featured story homepage
this is a test
Testing the archive option on posts
Aenean rhoncus, massa interdum commodo hendrerit, ipsum sapien sagittis nunc, eu dignissim massa ipsum id ex.
Testing the featured story placement
This is a test for the featured story placement going below the top stories Also checking if we already have the revisions in place. adding more stuff and changes to test the versioning
Home page right section post
This is a test to make sure the homepage curations is working as expected.
Heard at HLTH: Cohere Health
CEO of Cohere Health, Siva Namasivayam details how the company provides technology to streamline the prior authorization process.
presented by
The home page duplicated the article
This is a testing of a duplicated article.
Butterfly Network CEO: 2024 is When We Get Our Mojo Back
From its heady unicorn days to being newly public to its current financial struggles, the portable ultrasound-on-a-chip company has seen it all. Now, its latest CEO has his work cut out for him. A return to revenue growth is what Joseph DeVivo is promising this year.
Medtronic CEO On the Company’s AI: This Isn’t About ChatGPT
Geoff Martha sought to establish a clear line between popular understanding of AI created by apps like ChatGPT and what he believes is the significant impact that Medtronic's AI-enabled products are already having on patients and other healthcare stakeholders today.
5 Healthcare Trends that Will Shape 2024
As we look into the future, 2024 promises a profound transformation. Here are five areas of focus for the upcoming year.
Heard at HLTH: Quantum Health
Quantum Health's Chief Product Officer, Dan Shur talks about the company’s recent Index Report on the changing landscape of healthcare consultants.
AI-Generated Drug Candidates Are Here, But Clinical Trial Wins Need More Time
Despite artificial intelligence’s growing role in drug research, a fully AI-generated molecule has yet to advance from discovery all the way through clinical development. A novel molecule may eventually meet that goal, but some industry observers say it’s too early to focus on winning a race that has many twists and turns yet to come.
What Do Physicians Really Think of AI?
Nearly half of physicians are equally excited and concerned about the use of AI in their field, according to a new AMA survey. Those who felt optimistic about AI cited reduced administrative burden as the number one benefit they’re seeking. Patient privacy and the impact to the patient-physician relationship were the most common reasons physicians cited for having reservations about AI.
How WellSpan Health Is Using Artisight’s Virtual Nursing Tech to Reduce Burnout
WellSpan Health launched a virtual nursing pilot involving Artisight’s smart hospital platform. So far, WellSpan’s nurses “are loving it,” said Erin Langmead, the health system’s interim director of clinical informatics and physician informatics support.
AI-Enabled Prescription Digital Therapeutics Should Be An Investment Priority
To identify true growth opportunities, investors must consider how companies are using AI to revolutionize the treatment journey. Some companies are doing just that via Software as a Medical Device (SaMD), particularly by developing prescription digital therapeutics (PDTs).
Building Trust in AI: Why All Health Organizations Need a Plan To Address AI Bias
To harness the best parts of AI — and avoid its worst possible outcomes — you need an AI strategy that not only includes technical implementation tactics but also prioritizes efforts to minimize bias, address ethical considerations, and build consumer trust and confidence.